Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
OtherToxicology

Nitrogen mustard-induced ex vivo human cornea injury model and therapeutic intervention by dexamethasone

Neha Mishra, Rama Kant, Kushal Kandhari, David A Ammar, Neera Tewari-Singh, Mina B. Pantcheva, J. Mark Petrash, Chapla Agarwal and Rajesh Agarwal
Journal of Pharmacology and Experimental Therapeutics July 20, 2023, JPET-AR-2023-001760; DOI: https://doi.org/10.1124/jpet.123.001760
Neha Mishra
1University of Colorado Anschutz Medical Campus, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rama Kant
1University of Colorado Anschutz Medical Campus, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kushal Kandhari
1University of Colorado Anschutz Medical Campus, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David A Ammar
2Lions Eye Institute for Transplant and Research, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neera Tewari-Singh
3Michigan State University, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mina B. Pantcheva
1University of Colorado Anschutz Medical Campus, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Mark Petrash
1University of Colorado Anschutz Medical Campus, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chapla Agarwal
1University of Colorado Anschutz Medical Campus, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rajesh Agarwal
1University of Colorado Anschutz Medical Campus, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rajesh Agarwal
  • For correspondence: RAJESH.AGARWAL@CUANSCHUTZ.EDU
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Sulfur mustard (SM), a vesicating agent first used during World War I, remains a potent threat as a chemical weapon to cause intentional/accidental chemical emergencies. Eyes are extremely susceptible to SM toxicity. Nitrogen mustard (NM), a bifunctional alkylating agent and potent analog of SM, is used in laboratories to study mustard vesicant-induced ocular toxicity. Previously, we showed that SM-/NM-induced injuries (in vivo and ex vivo rabbit corneas) are reversed upon dexamethasone (DEX) treatment, an FDA approved, steroidal anti-inflammatory drug. Here, we optimized NM injuries in ex vivo human corneas and assessed DEX efficacy. For injury optimization, one cornea (randomly selected from paired eyes) was exposed to NM: 100 nmoles for 2 h or 4 h, and 200 nmoles for 2 h, and the other cornea served as a control. Injuries were assessed 24 h post NM-exposure. NM 100 nmoles exposure for 2 h was found to cause optimal corneal injury (epithelial thinning [~69%]; epithelial-stromal separation [6-fold increase]). In protein arrays studies, 24 proteins displayed {greater than or equal to}40% change in their expression in NM exposed corneas compared to controls. DEX administration initiated 2 h post NM exposure and every 8 h thereafter until 24 h post-exposure reversed NM-induced corneal epithelial-stromal separation [2-fold decrease]). Of the 24 proteins dysregulated upon NM exposure, 6 proteins (DLL1, FGFbasic, CD54, CCL7, endostatin, ERBB4) associated with angiogenesis, immune/inflammatory responses, and cell differentiation/proliferation, showed significant reversal upon DEX treatment (Student's t-test; p{less than or equal to}0.05). Complementing our animal model studies, DEX was shown to mitigate vesicant-induced toxicities in ex vivo human corneas.

Significance Statement NM exposure-induced injuries were optimized in an ex vivo human cornea culture model and studies were carried out at 24 h post 100 nmoles NM exposure. DEX administration (started 2 h post NM exposure and every 8 h thereafter) reversed NM-induced corneal injuries. Molecular mediators of DEX action were associated with angiogenesis, immune/inflammatory responses, and cell differentiation/proliferation, indicating DEX aids wound healing via reversing vesicant-induced neovascularization (DLL1 and FGF basic) and leukocyte infiltration (CD54 and CCL7).

  • cornea
  • dexamethasone
  • Copyright © 2023 American Society for Pharmacology and Experimental Therapeutics
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 387 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 387, Issue 1
1 Oct 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Nitrogen mustard-induced ex vivo human cornea injury model and therapeutic intervention by dexamethasone
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherToxicology

DEX attenuates NM exposure injuries in Ex vivo human corneas

Neha Mishra, Rama Kant, Kushal Kandhari, David A Ammar, Neera Tewari-Singh, Mina B. Pantcheva, J. Mark Petrash, Chapla Agarwal and Rajesh Agarwal
Journal of Pharmacology and Experimental Therapeutics July 20, 2023, JPET-AR-2023-001760; DOI: https://doi.org/10.1124/jpet.123.001760

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherToxicology

DEX attenuates NM exposure injuries in Ex vivo human corneas

Neha Mishra, Rama Kant, Kushal Kandhari, David A Ammar, Neera Tewari-Singh, Mina B. Pantcheva, J. Mark Petrash, Chapla Agarwal and Rajesh Agarwal
Journal of Pharmacology and Experimental Therapeutics July 20, 2023, JPET-AR-2023-001760; DOI: https://doi.org/10.1124/jpet.123.001760
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Positron Emission Tomography (PET) of [11C]Paraoxon in Rat
  • Clinical effects of dermal exposure to phosgene oxime
  • organophosphates induced chronic epilepsy
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics